Description of unilateral kidney embolism and contralateral nephrectomy as a less invasive remnant kidney model in cats; a proof‐of‐concept study
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Chad W Schmiedt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Nephrectomy, Disease Models, Animal, Embolism, Kidney. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim Vetmedica.
Abstract (Originalsprache)
Background
Refined models of kidney disease are critical to better understand disease processes and study novel treatments while minimizing discomfort in research animals. The objective of this study was to report a technique for minimally invasive partial kidney embolism in cats and describe outcomes following transcatheter administration of embolic microspheres with subsequent contralateral nephrectomy.
Methods
Eleven, apparently healthy, male, purpose‐bred cats underwent unilateral kidney embolism with 0.25 or 0.5 mL of embolic microparticle (40–120 μm) suspension (0.2 mL microspheres/mL) delivered into the right renal artery under fluoroscopic guidance, followed 5 months later by contralateral nephrectomy. One month after nephrectomy, blood and urinary markers of kidney function were evaluated, and embolized kidneys were harvested for histopathology evaluation.
Results
Renal artery embolization was possible in all cats. Two cats did not complete the study, one after experiencing congestive heart failure ( n = 1) and the other following evidence of complete kidney embolism precluding nephrectomy ( n = 1) post‐embolization. At study end, compared to baseline, cats had significant increases in median (range) serum creatinine (159.1 μmol/L [141.4–530.4] versus 128.2 μmol/L [92.8–150.3]; p = 0.0004), urea nitrogen (15.71 mmol/L [9.29–47.85] versus 7.50 mmol/L [6.07–8.57]; p < 0.0001), and symmetric dimethylarginine (0.74 μmol/L [0.59–3.12] versus 0.67 μmol/L [0.54–0.72]; p = 0.0288) concentrations. No differences in markers of kidney function were documented between dose groups.
Conclusions
Minimally invasive kidney embolism is a promising technique for modeling kidney disease in cats. Understanding optimal dose, timing of nephrectomy, and longer‐term consequences requires additional work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
- Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
ORCID-Profile: Chad W Schmiedt, Bianca N Lourenço
Förderung
- Boehringer Ingelheim Vetmedica
Zitieren
APA
Schmiedt, C. W., Lourenço, B. N., Markovic, L. E., Lancaster, M., Gumber, S., Wannemacher, J., Florian, P., & Coleman, A. E. (2025). Description of unilateral kidney embolism and contralateral nephrectomy as a less invasive remnant kidney model in cats; a proof‐of‐concept study. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70001
Vancouver
Schmiedt CW, Lourenço BN, Markovic LE, Lancaster M, Gumber S, Wannemacher J, et al. Description of unilateral kidney embolism and contralateral nephrectomy as a less invasive remnant kidney model in cats; a proof‐of‐concept study. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70001
BibTeX
@article{Schmiedt2025,
author = {Schmiedt, Chad W and Lourenço, Bianca N and Markovic, Lauren E and Lancaster, Meghan and Gumber, Sanjeev and Wannemacher, Juliane and Florian, Peter and Coleman, Amanda E},
title = {Description of unilateral kidney embolism and contralateral nephrectomy as a less invasive remnant kidney model in cats; a proof‐of‐concept study},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.70001}
}
EUVIMED